EUCOPE News by Category — News

Filtered by Category: News

News / Press Releases - April 16, 2025

Joint EUCOPE – IFPMA statement to support the adoption of the WHA Resolution on Rare Diseases

    16 April 2025, Geneva –  The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), representing the innovative pharmaceutical industry worldwide, and the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), representing small and mid-sized innovative health technology companies in Europe, welcome and echo the Call… read more

News - April 8, 2025

EUCOPE statement on the European Commission’s Strategic Dialogue with the pharmaceutical sector and the potential of tariffs

Brussels, 8 April, 2025 – This morning, EUCOPE’s Secretary General, Dr Alexander Natz, joined the European Commission’s Strategic Dialogue with the pharmaceutical sector. We thank Commission President von der Leyen for convening this meeting as an important opportunity to share the perspective of the innovative… read more

News - March 4, 2025

EUCOPE’s Sounds of Science Podcast – Episode #20 Tackling Medicine Shortages: The Role of EU Policies

Sounds of Science – episode 20 Tackling Medicine Shortages: the role of EU Policies Medicine shortages are a growing challenge across Europe, impacting patients, healthcare systems, and companies alike. But how is the EU tackling this issue? What role do EU policies and the upcoming… read more

EUCOPE Resources / News - February 11, 2025

EUCOPE’s Sounds of Science Podcast – Episode #19 Building a competitive pharmaceutical ecosystem: EUCOPE’s call to EU Institutions

EUCOPE’s Sounds of Science Podcast – Episode 19 Building a competitive pharmaceutical ecosystem: EUCOPE’s call to EU Institutions In this episode of Sounds of Science, we invited our members, Toon Digneffe and Enrico Piccinini, to discuss with Alexander Natz how the EU’s competitiveness strategies may… read more

Member Spotlight / News - December 19, 2024

EUCOPE Member Spotlight: Q&A with Catherine Owen Adams, CEO of Acadia Pharmaceuticals

Regularly, EUCOPE spotlights a member company and the great work it’s doing to advance the life sciences industry and drive innovation to serve patients better. For the December edition, we spoke with Catherine Owen Adams, CEO of Acadia Pharmaceuticals. Tell us about your organization and… read more

News / Press Releases - December 4, 2024

Pharmaceutical innovators are concerned over not enough advice meetings being offered in 2025 for discussing trial designs and evidence generation plans, with serious ramifications on the ability to undergo Joint Clinical Assessments

ARM, EFPIA, EUCOPE, EuropaBio, Vaccines Europe From 12 January 2025 the Regulation (EU) 2021/2282 on health technology assessment will apply and the first Joint Clinical Assessments (JCA) will be performed to assess the relative clinical effectiveness of new innovative cancer therapies and cell and gene… read more